Status:
COMPLETED
Intracellular Counter-regulatory Mechanisms Following Low Blood Glucose
Lead Sponsor:
University of Aarhus
Conditions:
Diabetes Mellitus Type I
Hypoglycemia
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Diabetes mellitus type I (DMI) is characterized by lack of endogenous insulin and these patients are 100% dependent on insulin substitution to survive. Diabetes mellitus type II (DMII) is characterize...
Eligibility Criteria
Inclusion
- BMI \> 19 and \< 26
- Written Consent
- Exclusion Criteria:
- Epilepsy
- Cardiac arrythmia
- Ischemic heart disease
- Other medical illness
Exclusion
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT01919788
Start Date
August 1 2013
End Date
April 1 2014
Last Update
September 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Clinical Medicine
Aarhus, Aarhus C, Denmark, 8000